Rezolute (RZLT) Invested Capital (2011 - 2022)

Rezolute (RZLT) posted Invested Capital of $15.7 million for Q1 2022, little changed sequentially from $15.7 million in Q4 2021.

Rezolute (RZLT) Invested Capital (2011 - 2022) Analysis & Trends

Rezolute has reported Invested Capital for 8 years, with the latest figure at $15.7 million in Q1 2022.

Quarterly Invested Capital changed N/A year-over-year to $15.7 million in Q1 2022, while the trailing twelve-month figure through Dec 2022 was $15.7 million (down 66.66% YoY) and the FY2021 annual result came in at $15.7 million, changed N/A from the prior year.
Invested Capital steadied at $15.7 million in Q1 2022 per RZLT's latest filing, from $15.7 million in the prior quarter.
Over five years, Invested Capital peaked at $15.7 million in Q2 2021 and troughed at $15.7 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	190.90 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	2.57 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	380.00 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	Rezolute	442.94 Mn	442.94 Mn	-	-

Download Data